Global Systemic Candidiasis Market Growth (Status and Outlook) 2025-2031

September 2025 | 97 pages | ID: GF756BF52FE9EN
LP Information

Abstracts

According to this study, the global Systemic Candidiasis market size will reach US$ million by 2031.

Systemic candidiasis includes a spectrum of yeast infections caused by different species (types) of Candida. It is a serious infection that can affect the blood, heart, brain, eyes, bones, or other parts of the body.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Systemic Candidiasis Industry Forecast” looks at past sales and reviews total world Systemic Candidiasis sales in 2024, providing a comprehensive analysis by region and market sector of projected Systemic Candidiasis sales for 2025 through 2031. With Systemic Candidiasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Candidiasis industry.

This Insight Report provides a comprehensive analysis of the global Systemic Candidiasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Systemic Candidiasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Candidiasis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Candidiasis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Candidiasis.

This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Candidiasis market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Systemic Oral Azoles
• Voriconazole
• Liposomal Amphotericin B
• Topical Antifungal Agents
• Others

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis Ag
• Sanofi-Aventis
• Pfizer, Inc.
• Merck And Co., Inc.
• Enzon Pharmaceuticals Inc.
• Bayer Ag
• Astellas Pharma, Inc.
• Glaxosmithkline Plc
• Abbott
• Cipla

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Systemic Candidiasis Market Size (2020-2031)
  2.1.2 Systemic Candidiasis Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Systemic Candidiasis by Country/Region (2020, 2024 & 2031)
2.2 Systemic Candidiasis Segment by Type
  2.2.1 Systemic Oral Azoles
  2.2.2 Voriconazole
  2.2.3 Liposomal Amphotericin B
  2.2.4 Topical Antifungal Agents
  2.2.5 Others
2.3 Systemic Candidiasis Market Size by Type
  2.3.1 Systemic Candidiasis Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Systemic Candidiasis Market Size Market Share by Type (2020-2025)
2.4 Systemic Candidiasis Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Systemic Candidiasis Market Size by Application
  2.5.1 Systemic Candidiasis Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Systemic Candidiasis Market Size Market Share by Application (2020-2025)

3 SYSTEMIC CANDIDIASIS MARKET SIZE BY PLAYER

3.1 Systemic Candidiasis Market Size Market Share by Player
  3.1.1 Global Systemic Candidiasis Revenue by Player (2020-2025)
  3.1.2 Global Systemic Candidiasis Revenue Market Share by Player (2020-2025)
3.2 Global Systemic Candidiasis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SYSTEMIC CANDIDIASIS BY REGION

4.1 Systemic Candidiasis Market Size by Region (2020-2025)
4.2 Global Systemic Candidiasis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Systemic Candidiasis Market Size Growth (2020-2025)
4.4 APAC Systemic Candidiasis Market Size Growth (2020-2025)
4.5 Europe Systemic Candidiasis Market Size Growth (2020-2025)
4.6 Middle East & Africa Systemic Candidiasis Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Systemic Candidiasis Market Size by Country (2020-2025)
5.2 Americas Systemic Candidiasis Market Size by Type (2020-2025)
5.3 Americas Systemic Candidiasis Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Systemic Candidiasis Market Size by Region (2020-2025)
6.2 APAC Systemic Candidiasis Market Size by Type (2020-2025)
6.3 APAC Systemic Candidiasis Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Systemic Candidiasis Market Size by Country (2020-2025)
7.2 Europe Systemic Candidiasis Market Size by Type (2020-2025)
7.3 Europe Systemic Candidiasis Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Systemic Candidiasis by Region (2020-2025)
8.2 Middle East & Africa Systemic Candidiasis Market Size by Type (2020-2025)
8.3 Middle East & Africa Systemic Candidiasis Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SYSTEMIC CANDIDIASIS MARKET FORECAST

10.1 Global Systemic Candidiasis Forecast by Region (2026-2031)
  10.1.1 Global Systemic Candidiasis Forecast by Region (2026-2031)
  10.1.2 Americas Systemic Candidiasis Forecast
  10.1.3 APAC Systemic Candidiasis Forecast
  10.1.4 Europe Systemic Candidiasis Forecast
  10.1.5 Middle East & Africa Systemic Candidiasis Forecast
10.2 Americas Systemic Candidiasis Forecast by Country (2026-2031)
  10.2.1 United States Market Systemic Candidiasis Forecast
  10.2.2 Canada Market Systemic Candidiasis Forecast
  10.2.3 Mexico Market Systemic Candidiasis Forecast
  10.2.4 Brazil Market Systemic Candidiasis Forecast
10.3 APAC Systemic Candidiasis Forecast by Region (2026-2031)
  10.3.1 China Systemic Candidiasis Market Forecast
  10.3.2 Japan Market Systemic Candidiasis Forecast
  10.3.3 Korea Market Systemic Candidiasis Forecast
  10.3.4 Southeast Asia Market Systemic Candidiasis Forecast
  10.3.5 India Market Systemic Candidiasis Forecast
  10.3.6 Australia Market Systemic Candidiasis Forecast
10.4 Europe Systemic Candidiasis Forecast by Country (2026-2031)
  10.4.1 Germany Market Systemic Candidiasis Forecast
  10.4.2 France Market Systemic Candidiasis Forecast
  10.4.3 UK Market Systemic Candidiasis Forecast
  10.4.4 Italy Market Systemic Candidiasis Forecast
  10.4.5 Russia Market Systemic Candidiasis Forecast
10.5 Middle East & Africa Systemic Candidiasis Forecast by Region (2026-2031)
  10.5.1 Egypt Market Systemic Candidiasis Forecast
  10.5.2 South Africa Market Systemic Candidiasis Forecast
  10.5.3 Israel Market Systemic Candidiasis Forecast
  10.5.4 Turkey Market Systemic Candidiasis Forecast
10.6 Global Systemic Candidiasis Forecast by Type (2026-2031)
10.7 Global Systemic Candidiasis Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Systemic Candidiasis Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis Ag
  11.1.1 Novartis Ag Company Information
  11.1.2 Novartis Ag Systemic Candidiasis Product Offered
  11.1.3 Novartis Ag Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis Ag Main Business Overview
  11.1.5 Novartis Ag Latest Developments
11.2 Sanofi-Aventis
  11.2.1 Sanofi-Aventis Company Information
  11.2.2 Sanofi-Aventis Systemic Candidiasis Product Offered
  11.2.3 Sanofi-Aventis Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sanofi-Aventis Main Business Overview
  11.2.5 Sanofi-Aventis Latest Developments
11.3 Pfizer, Inc.
  11.3.1 Pfizer, Inc. Company Information
  11.3.2 Pfizer, Inc. Systemic Candidiasis Product Offered
  11.3.3 Pfizer, Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer, Inc. Main Business Overview
  11.3.5 Pfizer, Inc. Latest Developments
11.4 Merck And Co., Inc.
  11.4.1 Merck And Co., Inc. Company Information
  11.4.2 Merck And Co., Inc. Systemic Candidiasis Product Offered
  11.4.3 Merck And Co., Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Merck And Co., Inc. Main Business Overview
  11.4.5 Merck And Co., Inc. Latest Developments
11.5 Enzon Pharmaceuticals Inc.
  11.5.1 Enzon Pharmaceuticals Inc. Company Information
  11.5.2 Enzon Pharmaceuticals Inc. Systemic Candidiasis Product Offered
  11.5.3 Enzon Pharmaceuticals Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Enzon Pharmaceuticals Inc. Main Business Overview
  11.5.5 Enzon Pharmaceuticals Inc. Latest Developments
11.6 Bayer Ag
  11.6.1 Bayer Ag Company Information
  11.6.2 Bayer Ag Systemic Candidiasis Product Offered
  11.6.3 Bayer Ag Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Bayer Ag Main Business Overview
  11.6.5 Bayer Ag Latest Developments
11.7 Astellas Pharma, Inc.
  11.7.1 Astellas Pharma, Inc. Company Information
  11.7.2 Astellas Pharma, Inc. Systemic Candidiasis Product Offered
  11.7.3 Astellas Pharma, Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Astellas Pharma, Inc. Main Business Overview
  11.7.5 Astellas Pharma, Inc. Latest Developments
11.8 Glaxosmithkline Plc
  11.8.1 Glaxosmithkline Plc Company Information
  11.8.2 Glaxosmithkline Plc Systemic Candidiasis Product Offered
  11.8.3 Glaxosmithkline Plc Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Glaxosmithkline Plc Main Business Overview
  11.8.5 Glaxosmithkline Plc Latest Developments
11.9 Abbott
  11.9.1 Abbott Company Information
  11.9.2 Abbott Systemic Candidiasis Product Offered
  11.9.3 Abbott Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Abbott Main Business Overview
  11.9.5 Abbott Latest Developments
11.10 Cipla
  11.10.1 Cipla Company Information
  11.10.2 Cipla Systemic Candidiasis Product Offered
  11.10.3 Cipla Systemic Candidiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Cipla Main Business Overview
  11.10.5 Cipla Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Systemic Candidiasis Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Systemic Candidiasis Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Systemic Oral Azoles
Table 4. Major Players of Voriconazole
Table 5. Major Players of Liposomal Amphotericin B
Table 6. Major Players of Topical Antifungal Agents
Table 7. Major Players of Others
Table 8. Systemic Candidiasis Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Systemic Candidiasis Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Systemic Candidiasis Market Size Market Share by Type (2020-2025)
Table 11. Systemic Candidiasis Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Systemic Candidiasis Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Systemic Candidiasis Market Size Market Share by Application (2020-2025)
Table 14. Global Systemic Candidiasis Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Systemic Candidiasis Revenue Market Share by Player (2020-2025)
Table 16. Systemic Candidiasis Key Players Head office and Products Offered
Table 17. Systemic Candidiasis Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Systemic Candidiasis Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Systemic Candidiasis Market Size Market Share by Region (2020-2025)
Table 22. Global Systemic Candidiasis Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Systemic Candidiasis Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Systemic Candidiasis Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Systemic Candidiasis Market Size Market Share by Country (2020-2025)
Table 26. Americas Systemic Candidiasis Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Systemic Candidiasis Market Size Market Share by Type (2020-2025)
Table 28. Americas Systemic Candidiasis Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Systemic Candidiasis Market Size Market Share by Application (2020-2025)
Table 30. APAC Systemic Candidiasis Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Systemic Candidiasis Market Size Market Share by Region (2020-2025)
Table 32. APAC Systemic Candidiasis Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Systemic Candidiasis Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Systemic Candidiasis Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Systemic Candidiasis Market Size Market Share by Country (2020-2025)
Table 36. Europe Systemic Candidiasis Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Systemic Candidiasis Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Systemic Candidiasis Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Systemic Candidiasis Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Systemic Candidiasis Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Systemic Candidiasis
Table 42. Key Market Challenges & Risks of Systemic Candidiasis
Table 43. Key Industry Trends of Systemic Candidiasis
Table 44. Global Systemic Candidiasis Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Systemic Candidiasis Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Systemic Candidiasis Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Systemic Candidiasis Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Novartis Ag Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 49. Novartis Ag Systemic Candidiasis Product Offered
Table 50. Novartis Ag Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Novartis Ag Main Business
Table 52. Novartis Ag Latest Developments
Table 53. Sanofi-Aventis Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 54. Sanofi-Aventis Systemic Candidiasis Product Offered
Table 55. Sanofi-Aventis Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Sanofi-Aventis Main Business
Table 57. Sanofi-Aventis Latest Developments
Table 58. Pfizer, Inc. Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 59. Pfizer, Inc. Systemic Candidiasis Product Offered
Table 60. Pfizer, Inc. Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Pfizer, Inc. Main Business
Table 62. Pfizer, Inc. Latest Developments
Table 63. Merck And Co., Inc. Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 64. Merck And Co., Inc. Systemic Candidiasis Product Offered
Table 65. Merck And Co., Inc. Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Merck And Co., Inc. Main Business
Table 67. Merck And Co., Inc. Latest Developments
Table 68. Enzon Pharmaceuticals Inc. Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 69. Enzon Pharmaceuticals Inc. Systemic Candidiasis Product Offered
Table 70. Enzon Pharmaceuticals Inc. Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Enzon Pharmaceuticals Inc. Main Business
Table 72. Enzon Pharmaceuticals Inc. Latest Developments
Table 73. Bayer Ag Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 74. Bayer Ag Systemic Candidiasis Product Offered
Table 75. Bayer Ag Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Bayer Ag Main Business
Table 77. Bayer Ag Latest Developments
Table 78. Astellas Pharma, Inc. Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 79. Astellas Pharma, Inc. Systemic Candidiasis Product Offered
Table 80. Astellas Pharma, Inc. Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Astellas Pharma, Inc. Main Business
Table 82. Astellas Pharma, Inc. Latest Developments
Table 83. Glaxosmithkline Plc Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 84. Glaxosmithkline Plc Systemic Candidiasis Product Offered
Table 85. Glaxosmithkline Plc Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Glaxosmithkline Plc Main Business
Table 87. Glaxosmithkline Plc Latest Developments
Table 88. Abbott Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 89. Abbott Systemic Candidiasis Product Offered
Table 90. Abbott Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. Cipla Details, Company Type, Systemic Candidiasis Area Served and Its Competitors
Table 94. Cipla Systemic Candidiasis Product Offered
Table 95. Cipla Systemic Candidiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Systemic Candidiasis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Systemic Candidiasis Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Systemic Candidiasis Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Systemic Candidiasis Sales Market Share by Country/Region (2024)
Figure 8. Systemic Candidiasis Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Systemic Candidiasis Market Size Market Share by Type in 2024
Figure 10. Systemic Candidiasis in Hospital
Figure 11. Global Systemic Candidiasis Market: Hospital (2020-2025) & ($ millions)
Figure 12. Systemic Candidiasis in Clinic
Figure 13. Global Systemic Candidiasis Market: Clinic (2020-2025) & ($ millions)
Figure 14. Systemic Candidiasis in Others
Figure 15. Global Systemic Candidiasis Market: Others (2020-2025) & ($ millions)
Figure 16. Global Systemic Candidiasis Market Size Market Share by Application in 2024
Figure 17. Global Systemic Candidiasis Revenue Market Share by Player in 2024
Figure 18. Global Systemic Candidiasis Market Size Market Share by Region (2020-2025)
Figure 19. Americas Systemic Candidiasis Market Size 2020-2025 ($ millions)
Figure 20. APAC Systemic Candidiasis Market Size 2020-2025 ($ millions)
Figure 21. Europe Systemic Candidiasis Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Systemic Candidiasis Market Size 2020-2025 ($ millions)
Figure 23. Americas Systemic Candidiasis Value Market Share by Country in 2024
Figure 24. United States Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Systemic Candidiasis Market Size Market Share by Region in 2024
Figure 29. APAC Systemic Candidiasis Market Size Market Share by Type (2020-2025)
Figure 30. APAC Systemic Candidiasis Market Size Market Share by Application (2020-2025)
Figure 31. China Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 35. India Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Systemic Candidiasis Market Size Market Share by Country in 2024
Figure 38. Europe Systemic Candidiasis Market Size Market Share by Type (2020-2025)
Figure 39. Europe Systemic Candidiasis Market Size Market Share by Application (2020-2025)
Figure 40. Germany Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 41. France Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Systemic Candidiasis Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Systemic Candidiasis Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Systemic Candidiasis Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Systemic Candidiasis Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 54. APAC Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 55. Europe Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 57. United States Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 58. Canada Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 59. Mexico Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 60. Brazil Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 61. China Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 62. Japan Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 63. Korea Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 65. India Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 66. Australia Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 67. Germany Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 68. France Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 69. UK Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 70. Italy Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 71. Russia Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 72. Egypt Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 73. South Africa Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 74. Israel Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 75. Turkey Systemic Candidiasis Market Size 2026-2031 ($ millions)
Figure 76. Global Systemic Candidiasis Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Systemic Candidiasis Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Systemic Candidiasis Market Size 2026-2031 ($ millions)